Related Experiment Video
Updated: Jun 6, 2026
10:09
Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
Impaired insulin turnover in islets from type 2 diabetic patients
Florian Ehehalt1, Klaus Knoch, Katja Erdmann
1Department of GI, Thoracic and Vascular Surgery, Dresden University of Technology, Germany.
Islets
|November 25, 2010
Summary
Impaired pancreatic beta-cell function in type 2 diabetes is linked to deficits in insulin biosynthesis. Nuclear retention of polypyrimidine tract-binding protein 1 (PTBP1) may hinder rapid insulin response to glucose.
Area of Science:
- Endocrinology
- Molecular Biology
- Diabetes Research
Background:
- Pancreatic beta-cell failure is central to type 2 diabetes pathogenesis.
- Molecular deficits in human diabetic islets remain poorly understood.
- Polypyrimidine tract-binding protein 1 (PTBP1) regulates insulin biosynthesis post-transcriptionally.
Purpose of the Study:
- To investigate molecular deficits in human type 2 diabetic islets.
- To examine the role of PTBP1 in glucose-stimulated insulin secretion.
- To understand the mechanisms underlying impaired insulin response in type 2 diabetes.
Main Methods:
- Islets isolated from type 2 diabetic and non-diabetic donors.
- Measurement of insulin content and secretion upon glucose stimulation.
- Assessment of PTBP1 subcellular localization (nuclear vs. cytoplasmic).
Main Results:
- Type 2 diabetic islets showed reduced total insulin increase after glucose stimulation.
- Non-diabetic islets exhibited decreased nuclear PTBP1 upon stimulation.
- Type 2 diabetic islets did not show decreased nuclear PTBP1, indicating impaired translocation.
Conclusions:
- Impaired rapid insulin increase in response to glucose is characteristic of type 2 diabetic islets.
- Nuclear retention of PTBP1 likely contributes to deficits in insulin secretion in type 2 diabetes.
- Understanding insulin biosynthesis and degradation is crucial for type 2 diabetes research.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...